anaptys

Anaptys Announces Stock Repurchase Plan

March 24, 2025 09:15 ET  | Source: AnaptysBio, Inc. SAN DIEGO, March 24, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq:…

2 weeks ago

Anaptys to Announce Top-line Data from Phase 2b Trial of Rosnilimab, a PD-1 Depleter and Agonist, in Rheumatoid Arthritis on Feb. 12, 2025

February 11, 2025 17:30 ET  | Source: AnaptysBio, Inc. SAN DIEGO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq:…

2 months ago